GlaxoSmithKline Biologicals S.A.;Glaxo Group Limited
发明人:
BROWN, James,METTENS, Pascal,MURPHY, Dennis
申请号：
HUE09781052
公开号：
HUE031044T2
申请日:
2009.07.24
申请国别(地区):
HU
年份:
2017
代理人:
摘要：
The present invention is directed to a polypeptide which comprises: (i) an Rv3616c protein sequence； (ii) a variant of an Rv3616c protein sequence； or (iii) an immunogenic fragment of an Rv3616c protein sequence for use in the treatment or prevention of latent TB. In other aspects the invention is directed to associated polynucleotides, fusion proteins and methods for the treatment or prevention of latent tuberculosis.
